KSE - Delayed Quote KRW

GC Biopharma Corp. (006280.KS)

Compare
172,400.00 -7,100.00 (-3.96%)
At close: 3:30:04 PM GMT+9

Research Analysis

Revenue vs. Earnings

Revenue 371.52B
Earnings 33.3B
Q4'23
Q1'24
Q2'24
Q3'24
0
100B
200B
300B
400B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

190,000.00
201,428.58 Average
172,400.00 Current
210,000.00 High

Earnings Estimate

Currency in KRW Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1177
Avg. Estimate -37.78102.23923.383,409.9
Low Estimate -37.78102.23-1,4001,352
High Estimate -37.78102.234,9645,064
Year Ago EPS -----2,333923.38

Revenue Estimate

Currency in KRW Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 5277
Avg. Estimate 463.34B409.65B1.71T1.87T
Low Estimate 450B399B1.69T1.82T
High Estimate 479.1B420.3B1.75T1.95T
Year Ago Sales 404.94B356.81B1.63T1.71T
Sales Growth (year/est) 14.42%14.81%5.15%9.48%

EPS Trend

Currency in KRW Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -37.78102.23923.383,409.9
7 Days Ago -124.1983.08924.583,420.5
30 Days Ago 0023.63,625.33
60 Days Ago 006884,781.17
90 Days Ago 00688.333,994.5

EPS Revisions

Currency in KRW Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 11----
Up Last 30 Days ----1--
Down Last 7 Days ------1
Down Last 30 Days ------2

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
006280.KS ----139.58%269.29%
S&P 500 5.00%12.00%2.10%12.20%

Related Tickers